Jason Turowski, MD

Appointed
2014

Education & Fellowships

Fellowship - Hospital of The University of Pennsylvania
Lung Transplantation and Advanced Lung Disease
Philadelphia, PA USA
2013

Fellowship - Hospital of The University of Pennsylvania
Pulmonary and Critical Care Medicine
Philadelphia, PA USA
2013

Residency - Johns Hopkins University School of Medicine
Internal Medicine
Baltimore, MD USA
2010

Medical School - Drexel University College of Medicine
M.D.
Philadelphia, PA USA
2007

Undergraduate - Drexel University
Philadelphia, PA USA
2003

Additional Training

• Management of patients with cystic fibrosis
  
  

Professional Highlights

• Graduated Summa Cum Laude from Drexel University in 2003
• Graduated Alpha Omega Alpha from Drexel University College of Medicine in 2007
• Completed the Osler Medical Residency at the Johns Hopkins Hospital by 2010, published in Chest
• Completed a Pulmonary and Critical Care Fellowship at the University of Pennsylvania 2010-2013
• Completed an Advanced Lung Disease and Lung Transplant Fellowship at Penn in 2012-2013
• Conducted a clinical trial assessing the role of antioxidants in patients with cystic fibrosis
• Pulse oximetry standardization project medical director for the Cleveland Clinic enterprise
• Appointed Associate Director of the Cleveland Clinic Adult Cystic Fibrosis Program

Certifications

• Internal Medicine
• Internal Medicine - Pulmonary Disease
• Internal Medicine - Critical Care Medicine

Specialty Interests

Lung Transplantation, Cystic Fibrosis Lung Transplant Transition Critical Care Medicine, Quality Improvement, Efficiency, Fellow Education

Awards & Honors

• Summa Cum Laude from Drexel University
• Alpha Omega Alpha
• Ronald J. Caputo Award 2007 for humanitarianism and excellence in the care of medical patients
• Osler Scholar
• First Advanced Lung Disease, Lung Transplant Fellow in Penn Medicine's history

Memberships

• American Medical Association
• American Thoracic Society
• International Society for Heart and Lung Transplant

See publications for Jason Turowski, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/17/2019, Dr. Turowski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.